How to Read a 7-OH Regulatory Announcement

To read a 7-OH announcement, identify the issuing agency, the kind of document, the substances covered, and the dates before summarizing what changed. A recommendation, a notice of intent, and an effective scheduling order are different steps; the temporary-scheduling statute separates the notice from the order. 21 U.S.C. 811(h)

This guide uses DEA's October 14, 2026 notice as a dated reading example, not a statement of legal status when you read it. It is educational, not legal or medical advice, and cannot determine whether a particular product or activity is lawful. This AI-assisted article has not undergone qualified legal or medical review. See our editorial methodology.

First identify the instrument, not the headline

Start with the agency name and the document's action field. Ask whether the text recommends action, announces intended action, or actually imposes controls. Do not replace those verbs with the blanket word "ban."

FDA's July 29, 2025 announcement recommended scheduling action and distinguished concentrated 7-OH products from natural kratom leaf. That announcement was not itself a DEA scheduling order. FDA recommendation announcement

The October DEA document's action field identifies a proposed amendment and notice of intent, based on a revised HHS recommendation dated October 8, 2026. To identify an effective order, locate the separate order, read its scope and effective-date language, and check later amendments or withdrawals; the notice is not a substitute. DEA notice, printed page 65370

Keep publication, filing, and effective dates separate

Make separate entries for when an announcement was issued or filed, when it appeared in the Federal Register, and when an operative requirement takes effect. If the last field is not established by the document, write "not established here" instead of guessing.

FDA's page describes notices issued October 9, 2026. The DEA PDF records filing on October 9 and publication on October 14. These dates describe different events, not contradictory effective dates. FDA October update; DEA PDF, pages 65370 and 65381

The notice identifies November 13, 2026 as the earliest publication date for the contemplated temporary order. That is not a guaranteed publication or effective date. A waiting period does not turn a notice into an order automatically. DEA notice, page 65370; temporary-scheduling procedure

Worked example: read the actual October 14 DEA notice

The source snapshot is October 14, 2026; recheck before using it for a later summary. Read the official published PDF for the notice wording and use the reader rendition to locate the document.

Document identity

The document is from DEA: docket DEA-1570, document 2026-20943, 91 FR 65370. A headline mentioning DEA does not establish that it refers to this instrument. Federal Register reader rendition

Action and proposed scope

The action is a notice of intent for threshold-based temporary Schedule I control of 7-OH and mitragynine pseudoindoxyl (MGPI). The notice does not implement the proposed thresholds immediately. DEA PDF, page 65370

The proposed scope covers either substance alone, or their combined amount when both are present. It includes isomers, esters, ethers, salts, and salts of isomers, esters, and ethers where possible. Mitragynine and MGPI are not interchangeable names. DEA PDF, page 65370

Existing controls are a separate entry

The notice says the August 26, 2026 MGPI order applies without a threshold until expiry or publication of a replacement and withdrawal of the prior order, whichever comes first. Proposing a threshold does not suspend that existing order. This is what the October notice reports, not an independent assessment of the August order. DEA PDF, page 65370

FDA also says August controls on MGPI, MGM-15, and MGM-16 remain in effect during the new notice period. Keep this existing-control statement separate from the proposed 7-OH/MGPI threshold approach. FDA October update

A careful example summary is: DEA published a revised notice of intent on October 14, 2026; this document does not establish an effective threshold-based order. Carry the date and link with that summary rather than turning it into an undated claim about today's law. DEA notice

Read the proposed thresholds as OR, not AND

The October notice describes two alternative criteria for either 7-OH or MGPI alone, or their combined amount when both are present:

• Concentration: greater than 1 milligram per gram for solid forms, or greater than 1 milligram per milliliter for liquid preparations. DEA notice, page 65370
• Ratio: mitragynine mass divided by the covered substance mass, using combined 7-OH plus MGPI mass when both are present, is less than 100; expressed as a mass ratio, less than 100:1. DEA notice, page 65370

The connector is OR: either criterion would satisfy the proposed threshold language. Requiring both changes its meaning. Preserve the strict comparisons; do not rewrite them as "at least" or "at most." DEA notice, page 65370

These are proposed regulatory criteria, not consumption limits. The notice explicitly says neither HHS nor DEA found below-threshold levels safe. Do not use these numbers to choose an amount, design a formulation, or declare a product lawful. DEA notice, Summary

FDA describes the revised approach as distinguishing trace botanical profiles from intentionally concentrated formulations. Natural kratom leaf and concentrated 7-OH products should not be collapsed into one category, but a botanical label is not a product assessment. FDA October update

Identify jurisdiction and the activity being discussed

A federal scheduling document is not a complete state-law answer. The CSA addresses the relationship with state law separately and does not simply exclude all state controls on the same subject. Other federal food and drug requirements also remain a separate question. 21 U.S.C. 903 and neighboring section 902

In your notes, name the jurisdiction and activity rather than writing "legal" or "illegal" without qualification. Possession, sale, manufacturing, importation, and research are different questions. This worksheet does not resolve any of them; ask a qualified legal professional about a real situation.

Later analysis is not a later order

The Congressional Research Service Legal Sidebar LSB11457, version 5, updated October 26, 2026, describes the October 14 documents as notices and reports the contemplated order-publication date as on or after November 13. That separately dated analysis can help explain the procedure; it is not an operative DEA order and does not change the date of the worked example. CRS analysis, pages 1-4

Locate any later order, correction, or withdrawal in the original agency record before drawing a current-status conclusion. A report update or webpage timestamp is not itself a new legal action.

Original notice-reading worksheet

Use these 13 fields to record what a source says and what remains unanswered. This is an original reading aid, not an agency form, compliance test, or safety checklist. Keep uncertain fields explicitly unknown.

• Exact title, agency, document number, and docket: record each identifier.
• Official PDF URL and relevant printed pages: keep the source beside your notes.
• Date you checked the source: distinguish your access date from document dates.
• Instrument: recommendation, notice, order, or another identified document type.
• Issue or filing date, and publication date: record these separately.
• Effective date and supporting passage: write "not established here" if this document does not establish one.
• Earliest contemplated action date, if stated: record it without making a prediction.
• Exact substances and included chemical forms: do not substitute similar names.
• Proposed or operative criteria: preserve units, OR/AND, and combined amounts.
• Existing controls: record what the source says about expiry, replacement, and withdrawal.
• Jurisdiction and activity: identify the separate sources still needed.
• Later order, correction, withdrawal, or update checked: include the document and check date.
• Remaining uncertainty and one-sentence dated summary: state what is still unknown.

For the worked notice, the effective-date entry is "this notice does not establish an effective threshold-based order," not "October 14" or "November 13." Attach the source to that entry. DEA notice, page 65370

Two follow-up questions

Does a notice period mean all related substances are uncontrolled?

No. In this example, the October notice expressly preserves the existing MGPI order pending expiry or replacement and withdrawal. Read existing and proposed controls separately. DEA notice

Can this example answer a legal-status question months later?

No. It records what the October 14 source says. Find and check later operative documents rather than silently advancing the example's date.

Complete the worksheet, then use the Regulatory Tracker to locate dated source records. For a separate health-evidence question, read Science and Evidence; for support pathways, visit Get Help. Regulatory wording is not a substitute for care or individualized legal advice.